Baxdela 450 (Delafloxacin Tablet) 450mg

Baxdela 450 is a fluoroquinolone antibiotic used to treat bacterial infections. It is effective against a range of Gram-positive and Gram-negative bacteria.

• Acute bacterial skin and skin structure infections (ABSSSI): Treats infections such as cellulitis, abscesses, and wound infections caused by susceptible bacteria.
• Community-acquired bacterial pneumonia (CABP): Effective against bacterial pneumonia acquired outside of healthcare settings.
• Skin infections caused by Staphylococcus aureus: Including methicillin-resistant and methicillin-susceptible strains.
• Skin infections caused by Streptococcus pyogenes: Treats infections caused by this common bacterial pathogen.

• Delafloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination. By disrupting these processes, it prevents bacterial growth and leads to the resolution of infections.

Baxdela 450 may cause various side effects, ranging from common to serious.

Common Side Effects

• Nausea: A common gastrointestinal side effect.
• Diarrhea: May occur during treatment.
• Headache: A frequent side effect reported by patients.
• Vomiting: Another common gastrointestinal reaction.
• Transaminase elevations: Increases in liver enzymes may be observed.
• Dizziness: Some patients may experience lightheadedness.
• Peripheral neuropathy: Numbness, tingling, or burning pain in the extremities.
• Hypoesthesia: Reduced sensitivity or sensation.

Serious or Rare Side Effects

• Tendinitis and tendon rupture: Inflammation or tearing of tendons, particularly in the Achilles tendon.
• Peripheral neuropathy: May lead to long-term nerve damage.
• Central nervous system effects: Includes convulsions, increased intracranial pressure, and toxic psychosis.
• Myasthenia gravis exacerbation: May worsen muscle weakness in patients with this condition.
• Clostridioides difficile-associated diarrhea: Severe diarrhea caused by bacterial infection.

Baxdela 450 should be used with caution and under medical supervision. Important precautions include:

• Avoid in patients with a history of tendon problems: Increased risk of tendinitis and tendon rupture.
• Monitor for peripheral neuropathy: Discontinue if symptoms such as numbness or tingling occur.
• Use with caution in patients with myasthenia gravis: May exacerbate muscle weakness.
• Avoid in patients with known hypersensitivity: Allergic reactions may occur.
• Separate administration from multivalent cations: Avoid taking with antacids or supplements containing magnesium, aluminum, or calcium.
• Store below 25°C: Keep in the original pack, protect from moisture.

Baxdela 450 may interact with other medications, potentially affecting its efficacy or increasing the risk of side effects.

Major Interactions (Avoid)

• Antacids: May significantly decrease the absorption of delafloxacin.
• Multivalent cations: Includes supplements containing magnesium, aluminum, or calcium.
• Sucralfate: Contains aluminum, which can reduce the absorption of delafloxacin.
• Other fluoroquinolones: May increase the risk of serious side effects.

Moderate Interactions (Monitor Closely)

• Nonsteroidal anti-inflammatory drugs (NSAIDs): May increase the risk of central nervous system effects.
• Corticosteroids: May increase the risk of tendon problems.
• Oral anticoagulants: May increase the risk of bleeding.
• Probenecid: May increase the concentration of delafloxacin in the blood.